{"id":"asc-j9-cream","_chembl":{"chemblId":"CHEMBL2108947","moleculeType":"Unknown"},"modality":"Small molecule","_dailymed":null,"_scrapedAt":"2026-03-28T02:29:27.558Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779123615,"model":"claude-sonnet-4-5-20250929"},"description":"ASC-J9 cream is an investigational topical formulation developed by AndroScience Corp, currently in Phase 2 clinical development. The compound is being evaluated as a potential treatment for dermatological conditions, though specific therapeutic targets and indications have not been publicly disclosed.","indications":{"approved":[{"status":"investigational","condition":null,"patientPopulation":null}]},"trialDetails":[{"nctId":"NCT01289574","phase":"PHASE2","title":"Topical ASC-J9 Cream for Acne","status":"COMPLETED","sponsor":"AndroScience Corp","startDate":"2011-02","conditions":"Acne","enrollment":181},{"nctId":"NCT00525499","phase":"PHASE2","title":"A Phase 2 Study of ASC-J9 Cream in Acne Vulgaris","status":"COMPLETED","sponsor":"AndroScience Corp","startDate":"2007-08","conditions":"Acne Vulgaris","enrollment":186}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"ASC-J9 cream","genericName":"ASC-J9 cream","companyName":"AndroScience Corp","companyId":"androscience-corp","firstApprovalDate":"","aiSummary":"","enrichmentLevel":1,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}